Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Schlessinger

Showing results (401-410 of 410) with videos related to

Pageof 41
Sort By:
You have reached the last page of results.This site can display upto 410 results.
Nature|December 17, 1992
Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinasesM Rozakis-Adcock, J McGlade, G Mbamalu, et al.
The EMBO Journal|October 17, 1998
Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domainM Mohammadi, S Froum, J M Hamby, et al.
Cell|July 28, 1995
The carbonic anhydrase domain of receptor tyrosine phosphatase beta is a functional ligand for the axonal cell recognition molecule contactinE Peles, M Nativ, P L Campbell, et al.
Growth Factors (Chur, Switzerland)|June 1, 2000
Stoichiometry, kinetic and binding analysis of the interaction between epidermal growth factor (EGF) and the extracellular domain of the EGF receptorT Domagala, N Konstantopoulos, F Smyth, et al.
Molecular and Cellular Biology|May 5, 2005
The docking protein FRS2alpha is an essential component of multiple fibroblast growth factor responses during early mouse developmentN Gotoh, K Manova, S Tanaka, et al.
Cancer Research|August 17, 2000
SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumorsA D Laird, P Vajkoczy, L K Shawver, et al.
Nature Communications|August 12, 2018
A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockersS N Gettinger, J Choi, N Mani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 9, 2017
Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune functionM Choi, H Kadara, J Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 25, 2018
Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-upH Kadara, M Choi, J Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2016
Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-upH Kadara, M Choi, J Zhang, et al.
Pageof 41

Showing results (401-410 of 410) with videos related to

Sort By:
Pageof 41
You have reached the last page of results.This site can display upto 410 results.
Nature|December 17, 1992
Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinasesM Rozakis-Adcock, J McGlade, G Mbamalu, et al.
The EMBO Journal|October 17, 1998
Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domainM Mohammadi, S Froum, J M Hamby, et al.
Cell|July 28, 1995
The carbonic anhydrase domain of receptor tyrosine phosphatase beta is a functional ligand for the axonal cell recognition molecule contactinE Peles, M Nativ, P L Campbell, et al.
Growth Factors (Chur, Switzerland)|June 1, 2000
Stoichiometry, kinetic and binding analysis of the interaction between epidermal growth factor (EGF) and the extracellular domain of the EGF receptorT Domagala, N Konstantopoulos, F Smyth, et al.
Molecular and Cellular Biology|May 5, 2005
The docking protein FRS2alpha is an essential component of multiple fibroblast growth factor responses during early mouse developmentN Gotoh, K Manova, S Tanaka, et al.
Cancer Research|August 17, 2000
SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumorsA D Laird, P Vajkoczy, L K Shawver, et al.
Nature Communications|August 12, 2018
A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockersS N Gettinger, J Choi, N Mani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 9, 2017
Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune functionM Choi, H Kadara, J Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 25, 2018
Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-upH Kadara, M Choi, J Zhang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 2016
Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-upH Kadara, M Choi, J Zhang, et al.
Pageof 41